KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Xwell (XWEL) EBITDA (2016 - 2025)

Xwell's EBITDA history spans 16 years, with the latest figure at -$9.5 million for Q4 2025.

  • On a quarterly basis, EBITDA fell 32.46% to -$9.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$15.6 million, a 4.76% increase, with the full-year FY2025 number at -$15.6 million, up 4.76% from a year prior.
  • EBITDA hit -$9.5 million in Q4 2025 for Xwell, down from -$121000.0 in the prior quarter.
  • Over the last five years, EBITDA for XWEL hit a ceiling of $6.5 million in Q3 2021 and a floor of -$14.2 million in Q4 2022.
  • Historically, EBITDA has averaged -$4.6 million across 5 years, with a median of -$4.8 million in 2021.
  • Biggest five-year swings in EBITDA: skyrocketed 198.76% in 2021 and later plummeted 887.77% in 2022.
  • Tracing XWEL's EBITDA over 5 years: stood at $1.8 million in 2021, then plummeted by 887.77% to -$14.2 million in 2022, then soared by 64.17% to -$5.1 million in 2023, then plummeted by 40.36% to -$7.2 million in 2024, then plummeted by 32.46% to -$9.5 million in 2025.
  • Business Quant data shows EBITDA for XWEL at -$9.5 million in Q4 2025, -$121000.0 in Q3 2025, and -$1.6 million in Q2 2025.